CompletedNot Applicable

Total Intravenous Anesthesia Versus Inhalation Anesthesia on Postoperative Liver Function

Egypt80 participantsStarted 2024-01-26

Plain-language summary

The pandemic of obesity has become a serious issue of public health worldwide as the size of the obese population has almost tripled over the last four decades and continues to riseزThe epidemic of obesity has led to a significant increase in the prevalence of non-alcoholic fatty liver disease (NAFLD). NAFLD is currently the most common chronic liver disease, with an estimated global prevalence at 25-30%, rising up to 90% in morbidly obese patients

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Obese patients * had ASA I-III * diagnosed with non-alcoholic steatohepatitis (NASH) liver disease * undergoing laparoscopic sleeve gastrectomy Exclusion Criteria: * cases wherein surgeries were performed using anesthetic methods that were not clearly identified as TIVA or INHA * heart surgery or cesarean section, and cases of neuromuscular diseases

What they're measuring

visual analogue scale

Timeframe: visual analogue scale was measured at day one and day two postoperatively

Trial details

NCT IDNCT06423846

SponsorBenha University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-06

View on ClinicalTrials.gov More Laparoscopic Sleeve Gastrectomy trials